Your browser doesn't support javascript.
loading
TRPM2 as a conserved gatekeeper determines the vulnerability of DA neurons by mediating ROS sensing and calcium dyshomeostasis.
Ye, Peiwu; Fang, Qiuyuan; Hu, Xupang; Zou, Wenjuan; Huang, Miaodan; Ke, Minjing; Li, Yunhao; Liu, Min; Cai, Xiaobo; Zhang, Congyi; Hua, Ning; Al-Sheikh, Umar; Liu, Xingyu; Yu, Peilin; Jiang, Peiran; Pan, Ping-Yue; Luo, Jianhong; Jiang, Lin-Hua; Xu, Suhong; Fang, Evandro F; Su, Huanxing; Kang, Lijun; Yang, Wei.
Afiliação
  • Ye P; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Fang Q; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Hu X; Second Clinical Medical College, Affiliated Secondary Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310011, China.
  • Zou W; Department of Neurobiology and Department of Neurosurgery of the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang 310053, China.
  • Huang M; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Ke M; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Li Y; Institute of Chinese Medical Sciences, University of Macau, Macau, China.
  • Liu M; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Cai X; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Zhang C; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Hua N; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Al-Sheikh U; Department of Neurobiology and Department of Neurosurgery of the First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang 310053, China.
  • Liu X; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China.
  • Yu P; Department of Toxicology, School of Public Health, Zhejiang University, Hangzhou, Zhejiang 310058, China.
  • Jiang P; School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou 310058, China.
  • Pan PY; Department of Neuroscience and Cell Biology, Rutgers University Robert Wood Johnson Medical School, 675 Hoes Lane, Piscataway, NJ 08854, USA.
  • Luo J; School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou 310058, China.
  • Jiang LH; School of Biomedical Sciences, University of Leeds, Leeds LS2 9JT, UK; Sino-UK Laboratory of Brain Function and Injury of Henan Province, Department of Physiology and Neurobiology, Xinxiang Medical University, Xinxiang 453000, China; University of Leeds, Leeds LS2 9JT, UK.
  • Xu S; Center for Stem Cell and Regenerative Medicine and Department of Cardiology of The Second Affiliated Hospital, Zhejiang University School of Medicine, 310058, Hangzhou, China.
  • Fang EF; Department of Clinical Molecular Biology, University of Oslo and Akershus University Hospital, Lørenskog, Norway.
  • Su H; Institute of Chinese Medical Sciences, University of Macau, Macau, China. Electronic address: huanxingsu@umac.mo.
  • Kang L; Second Clinical Medical College, Affiliated Secondary Hospital, Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310011, China; School of Brain Science and Brain Medicine, Zhejiang University, Hangzhou 310058, China. Electronic address: kanglijun@zju.edu.cn.
  • Yang W; Department of Biophysics, Institute of Neuroscience, NHC and CAMS Key Laboratory of Medical Neurobiology, Zhejiang University School of Medicine, Hangzhou 310058, China. Electronic address: yangwei@zju.edu.cn.
Prog Neurobiol ; 231: 102530, 2023 Dec.
Article em En | MEDLINE | ID: mdl-37739206
ABSTRACT
Different dopaminergic (DA) neuronal subgroups exhibit distinct vulnerability to stress, while the underlying mechanisms are elusive. Here we report that the transient receptor potential melastatin 2 (TRPM2) channel is preferentially expressed in vulnerable DA neuronal subgroups, which correlates positively with aging in Parkinson's Disease (PD) patients. Overexpression of human TRPM2 in the DA neurons of C. elegans resulted in selective death of ADE but not CEP neurons in aged worms. Mechanistically, TRPM2 activation mediates FZO-1/CED-9-dependent mitochondrial hyperfusion and mitochondrial permeability transition (MPT), leading to ADE death. In mice, TRPM2 knockout reduced vulnerable substantia nigra pars compacta (SNc) DA neuronal death induced by stress. Moreover, the TRPM2-mediated vulnerable DA neuronal death pathway is conserved from C. elegans to toxin-treated mice model and PD patient iPSC-derived DA neurons. The vulnerable SNc DA neuronal loss is the major symptom and cause of PD, and therefore the TRPM2-mediated pathway serves as a promising therapeutic target against PD.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas de Caenorhabditis elegans / Canais de Cátion TRPM Limite: Aged / Animals / Humans Idioma: En Revista: Prog Neurobiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Doença de Parkinson / Proteínas de Caenorhabditis elegans / Canais de Cátion TRPM Limite: Aged / Animals / Humans Idioma: En Revista: Prog Neurobiol Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China